Jul 20, 2019
Upsher-Smith Laboratories Completes Acquisition Of Two Treatments For Acute Migraine In Adults
Nov 28, 2018
Perrigo Announces Patent Litigation Settlement For The Generic Version Of Sernivo® Spray, 0.05%
Jun 27, 2018
Promius Pharma Announces Migraine Presentations at the 60th Annual Scientific Meeting of the American Headache Society
May 24, 2018
Promius Pharma Dermatology Marketing Team Named 2018 PM360 ELITE 100 Winner
May 24, 2018
Perrigo Confirms Patent Challenge For Generic Version Of Sernivo® Spray, 0.05%
Apr 21, 2018
Progress in Migraine Research, Promius Announces Presentations for the 70th American Academy of Neurology Annual Meeting
Nov 15, 2017
Promius Pharma Announces ZEMBRACE® SymTouch® (Sumatriptan Injection) 3 mg Achieves Primary Endpoint in Post-Approval Clinical Trial
Nov 13, 2017
Promius Pharma Employees Band Together to Fundraise for Hurricane Victims
Nov 09, 2017
Promius Pharma Initiates Phase 3 Clinical Trials of DFD-03 for The Treatment of Acne Vulgaris
Oct 13, 2017
Focus on psoriasis; Promius Pharma announces 4 posters regarding SERNIVO® (betamethasone dipropionate) Spray, 0.05% at Fall Clinical Dermatology Conference®
Oct 13, 2017
Announcing progress in dermatological research, Promius Pharma shares 9 posters at Fall Clinical Dermatology Conference®
Sep 26, 2017
Promius Pharma Named PM360 Silver Winner Trailblazer Specialty Pharma/Biotech Company of the Year
Sep 07, 2017
Promius Pharma Presents Positive Results for Phase 2 Study of DFN-02, a Novel Intranasal Formulation of Sumatriptan, at 18th Congress of the International Headache Society
Sep 07, 2017
Promius Pharma to Present 3 Posters, Including a Podium Presentation, from MAST Study--the Largest Online Longitudinal Epidemiological Survey of Episodic/Chronic Migraine in the United States
Sep 06, 2017
Promius Pharma's Harshal Deshpande Named PM360 Trailblazer 2017 Brand Champion for Pain/Inflammation
Jun 23, 2017
Promius Pharma Launches No Time 4 Migraines PSA to Educate Patients and Caregivers During Migraine Awareness Month
Jun 09, 2017
Migraine Research Team, Including Dr Sagar Munjal and Dr Alix Bennett of Promius Pharma, Honored at AHS 2017 With the Harold G. Wolff Lecture Award
Jun 08, 2017
Promius Pharma to Present Two Posters From MAST Study, the Largest Online Longitudinal Epidemiological Survey of Episodic/Chronic Migraine in the United States
Jun 07, 2017
Promius Pharma Announces Positive Results for Phase 2 Study of DFN-02, a Novel Intranasal Formulation of Sumatriptan
Jun 07, 2017
Promius Pharma to Present Innovative Scientific Results From Migraine Studies at the 59th Annual Scientific Meeting of the American Headache Society